Healthcare provider profile · identity verified

Collin G Cherry, MD

Internal Medicine · CHATTANOOGA, TN · NPI 1659375491

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	509	150
Amlodipine Besylate	Amlodipine Besylate	343	100
Lisinopril	Lisinopril	322	96
Rosuvastatin Calcium	Rosuvastatin Calcium	312	99
Meloxicam	Meloxicam	295	98
Levothyroxine Sodium	Levothyroxine Sodium	292	81
Pantoprazole Sodium	Pantoprazole Sodium	290	92
Metformin Hcl	Metformin Hcl	254	81
Tamsulosin Hcl	Tamsulosin Hcl	254	76
Pravastatin Sodium	Pravastatin Sodium	242	67
Losartan Potassium	Losartan Potassium	237	71
Telmisartan	Telmisartan	231	65
Omeprazole	Omeprazole	215	66
Metoprolol Succinate	Metoprolol Succinate	204	67
Allopurinol	Allopurinol	188	51
Duloxetine Hcl	Duloxetine Hcl	180	51
Simvastatin	Simvastatin	179	53
Lorazepam	Lorazepam	172	32
Escitalopram Oxalate	Escitalopram Oxalate	161	53
Trazodone Hcl	Trazodone Hcl	147	44
Potassium Chloride	Potassium Chloride	144	40
Furosemide	Furosemide	139	44
Gabapentin	Gabapentin	137	54
Finasteride	Finasteride	106	30
Eliquis	Apixaban	104	25
Citalopram Hbr	Citalopram Hydrobromide	100	28
Hydrochlorothiazide	Hydrochlorothiazide	100	41
Bupropion Xl	Bupropion Hcl	99	33
Azithromycin	Azithromycin	98	81
Mirtazapine	Mirtazapine	89	31
Cefuroxime	Cefuroxime Axetil	79	61
Bumetanide	Bumetanide	77	18
Spironolactone	Spironolactone	77	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	75	26
Jardiance	Empagliflozin	73	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	72	18
Glipizide	Glipizide	68	17
Methylprednisolone	Methylprednisolone	61	57
Ozempic	Semaglutide	60	11
Metoprolol Tartrate	Metoprolol Tartrate	59	20
Donepezil Hcl	Donepezil Hcl	58	17
Sertraline Hcl	Sertraline Hcl	57	20
Zolpidem Tartrate	Zolpidem Tartrate	57	14
Carvedilol	Carvedilol	55	23
Clopidogrel	Clopidogrel Bisulfate	55	21
Prednisone	Prednisone	55	19
Venlafaxine Hcl Er	Venlafaxine Hcl	55	16
Olmesartan Medoxomil	Olmesartan Medoxomil	53	16
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	51	14
Dilt-Xr	Diltiazem Hcl	47	13
Albuterol Sulfate Hfa	Albuterol Sulfate	46	19
Januvia	Sitagliptin Phosphate	45	suppressed
Synthroid	Levothyroxine Sodium	45	12
Tizanidine Hcl	Tizanidine Hcl	44	22
Mounjaro	Tirzepatide	43	suppressed
Topiramate	Topiramate	43	12
Tramadol Hcl	Tramadol Hcl	43	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	14
Ibandronate Sodium	Ibandronate Sodium	41	15
Benazepril Hcl	Benazepril Hcl	40	12
Celecoxib	Celecoxib	39	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	14
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	25
Verapamil Er	Verapamil Hcl	36	13
Montelukast Sodium	Montelukast Sodium	35	12
Valacyclovir	Valacyclovir Hcl	35	12
Clonazepam	Clonazepam	32	suppressed
Farxiga	Dapagliflozin Propanediol	32	suppressed
Ketoconazole	Ketoconazole	32	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	11
Levofloxacin	Levofloxacin	29	22
Pregabalin	Pregabalin	29	13
Warfarin Sodium	Warfarin Sodium	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	18
Famotidine	Famotidine	25	suppressed
Cefadroxil	Cefadroxil	24	16
Estradiol	Estradiol	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	20
Atenolol	Atenolol	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Glipizide Er	Glipizide	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Klor-Con M10	Potassium Chloride	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Jantoven	Warfarin Sodium	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Lactulose	Lactulose	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error